{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:26:52Z","timestamp":1783636012170,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA247801"],"award-info":[{"award-number":["T32CA247801"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R38CA245095"],"award-info":[{"award-number":["R38CA245095"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.gassur.2024.06.025","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T18:11:40Z","timestamp":1719943900000},"page":"1512-1518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Utilization of neoadjuvant therapy for localized gastric gastrointestinal stromal tumors and the association with survival"],"prefix":"10.1016","volume":"28","author":[{"given":"Lauren M.","family":"Janczewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic J.","family":"Vitello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha C.","family":"Warwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna T.","family":"Buchheit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Pollack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Viveiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bentrem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Wayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gassur.2024.06.025_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.gtc.2013.01.001","article-title":"Gastrointestinal stromal tumors","volume":"42","author":"Miettinen","year":"2013","journal-title":"Gastroenterol Clin North Am"},{"issue":"15","key":"10.1016\/j.gassur.2024.06.025_bib2","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.3390\/cancers14153689","article-title":"Gastrointestinal stromal tumors (GIST): a population-based study using the SEER Database, including Management and Recent Advances in Targeted Therapy","volume":"14","author":"Khan","year":"2022","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.gassur.2024.06.025_bib3","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/bjs.10809","article-title":"Nationwide trends in the incidence and outcome of patients with gastrointestinal stromal tumour in the imatinib era","volume":"105","author":"van der Graaf","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.gassur.2024.06.025_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev-med-043010-091813","article-title":"The management of gastrointestinal stromal tumors: a model for targeted and multidisciplinary therapy of malignancy","volume":"63","author":"Joensuu","year":"2012","journal-title":"Annu Rev Med"},{"issue":"1","key":"10.1016\/j.gassur.2024.06.025_bib5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/1055-9965.EPI-14-1002","article-title":"Epidemiology of gastrointestinal stromal tumors in the era of histology codes: results of a population-based study","volume":"24","author":"Ma","year":"2015","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"2","key":"10.1016\/j.gassur.2024.06.025_bib6","article-title":"Incidence of gastrointestinal stromal tumors in the United States from 2001-2015: a United States cancer statistics analysis of 50 states","volume":"11","author":"Patel","year":"2019","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.gassur.2024.06.025_bib7","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/cncr.20862","article-title":"Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era\u2014a population-based study in western Sweden","volume":"103","author":"Nilsson","year":"2005","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.gassur.2024.06.025_bib8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.6004\/jnccn.2022.0058","article-title":"NCCN Guidelines insights: gastrointestinal stromal tumors, version 2.2022","volume":"20","author":"von Mehren","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.gassur.2024.06.025_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10120-015-0526-8","article-title":"The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines","volume":"19","author":"Nishida","year":"2016","journal-title":"Gastric Cancer"},{"issue":"12","key":"10.1016\/j.gassur.2024.06.025_bib10","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1245\/s10434-006-9047-3","article-title":"Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era","volume":"13","author":"Bonvalot","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.gassur.2024.06.025_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1200\/JCO.2017.74.9705","article-title":"Gastrointestinal stromal tumors","volume":"36","author":"von Mehren","year":"2018","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.gassur.2024.06.025_bib12","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1200\/JCO.2013.51.2046","article-title":"Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial","volume":"32","author":"Corless","year":"2014","journal-title":"J Clin Oncol"},{"issue":"9669","key":"10.1016\/j.gassur.2024.06.025_bib13","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(09)60500-6","article-title":"Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial","volume":"373","author":"Dematteo","year":"2009","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.gassur.2024.06.025_bib14","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.2012.347","article-title":"One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial","volume":"307","author":"Joensuu","year":"2012","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.gassur.2024.06.025_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1200\/JCO.2015.62.9170","article-title":"Adjuvant Imatinib for high-risk GI stromal tumor: analysis of a randomized trial","volume":"34","author":"Joensuu","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2024.06.025_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1245\/s10434-006-9034-8","article-title":"Surgical resection of gastrointestinal stromal tumors after treatment with imatinib","volume":"14","author":"Andtbacka","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.gassur.2024.06.025_bib17","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1245\/s10434-014-3632-7","article-title":"Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors","volume":"21","author":"Bednarski","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"10.1016\/j.gassur.2024.06.025_bib18","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1245\/s10434-017-6087-9","article-title":"Rectal gastrointestinal stromal tumor (GIST) in the era of imatinib: organ preservation and improved oncologic outcome","volume":"24","author":"Cavnar","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2024.06.025_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jso.21160","article-title":"Phase II trial of neoadjuvant\/adjuvant imatinib mesylate (IM) for advanced primary and metastatic\/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132\/ACRIN 6665","volume":"99","author":"Eisenberg","year":"2009","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2024.06.025_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/bjc.2017.144","article-title":"Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach","volume":"117","author":"Kurokawa","year":"2017","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.gassur.2024.06.025_bib21","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1245\/s10434-013-3013-7","article-title":"Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience","volume":"20","author":"Rutkowski","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.gassur.2024.06.025_bib22","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1245\/s10434-011-2190-5","article-title":"Phase II trial of neoadjuvant\/adjuvant imatinib mesylate for advanced primary and metastatic\/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132","volume":"19","author":"Wang","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.gassur.2024.06.025_bib23","unstructured":"NCCN clinical practice guidelines in oncology version 2; 2021. Accessed 01 December 2023. Treatment by Cancer Type (nccn.org)."},{"issue":"8","key":"10.1016\/j.gassur.2024.06.025_bib24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jso.21173","article-title":"Using the NCDB for cancer care improvement: an introduction to available quality assessment tools","volume":"99","author":"Raval","year":"2009","journal-title":"J Surg Oncol"},{"issue":"12","key":"10.1016\/j.gassur.2024.06.025_bib25","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","article-title":"Using the national cancer database for outcomes research: a review","volume":"3","author":"Boffa","year":"2017","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.gassur.2024.06.025_bib26","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1245\/s10434-019-07213-1","article-title":"Incident cases captured in the national cancer database compared with those in U.S. population based central cancer registries in 2012-2014","volume":"26","author":"Mallin","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.gassur.2024.06.025_bib27","unstructured":"Cancer programs: national cancer database: participant user files. American College of Surgeons. Available from: \u3008https:\/\/www.facs.org\/quality-programs\/cancer-programs\/national-cancer-database\/puf\/\u3009 [Accessed 1 Nov 2022]."},{"issue":"5","key":"10.1016\/j.gassur.2024.06.025_bib28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/COC.0b013e31821954a7","article-title":"Laparoscopic versus open resection of gastric gastrointestinal stromal tumors","volume":"35","author":"Melstrom","year":"2012","journal-title":"Am J Clin Oncol"},{"issue":"7","key":"10.1016\/j.gassur.2024.06.025_bib29","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/jso.27233","article-title":"The inaccuracies of gastric adenocarcinoma clinical staging and its predictive factors","volume":"127","author":"Janczewski","year":"2023","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2024.06.025_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1245\/s10434-011-1842-9","article-title":"Incorporation of adjuvant therapy into the multimodality management of gastrointestinal stromal tumors of the stomach in the United States","volume":"19","author":"Bilimoria","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.gassur.2024.06.025_bib31","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.amjsurg.2019.10.014","article-title":"Adjuvant systemic therapy for intermediate and large gastric gastrointestinal stromal tumors (GISTs): is there a survival benefit following margin negative surgical resection?","volume":"219","author":"Patel","year":"2020","journal-title":"Am J Surg"},{"issue":"9","key":"10.1016\/j.gassur.2024.06.025_bib32","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1007\/s11605-023-05742-5","article-title":"Utilization of neoadjuvant therapy in gastrointestinal stromal tumors of the stomach: analysis of the 2006-2018 national cancer database","volume":"27","author":"Kelly","year":"2023","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.gassur.2024.06.025_bib33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11605-019-04344-4","article-title":"The impact of imatinib on survival and treatment trends for small bowel and colorectal gastrointestinal stromal tumors","volume":"24","author":"Almaazmi","year":"2020","journal-title":"J Gastrointest Surg"},{"issue":"7","key":"10.1016\/j.gassur.2024.06.025_bib34","article-title":"Evaluation of and current trends in the management of gastrointestinal stromal tumors: a systematic review","volume":"14","author":"Arzoun","year":"2022","journal-title":"Cureus"},{"issue":"15","key":"10.1016\/j.gassur.2024.06.025_bib35","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1200\/JCO.2016.71.0228","volume":"35","author":"Casali","year":"2017","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.gassur.2024.06.025_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1470-2045(11)70299-6","article-title":"Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts","volume":"13","author":"Joensuu","year":"2012","journal-title":"Lancet Oncol"},{"issue":"13","key":"10.1016\/j.gassur.2024.06.025_bib37","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/bjs.10931","article-title":"Overall survival before and after centralization of gastric cancer surgery in the Netherlands","volume":"105","author":"van Putten","year":"2018","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.gassur.2024.06.025_bib38","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00464-018-6393-8","article-title":"Laparoscopic versus open resection of gastrointestinal stromal tumors: survival outcomes from the NCDB","volume":"33","author":"Inaba","year":"2019","journal-title":"Surg Endosc"},{"issue":"11","key":"10.1016\/j.gassur.2024.06.025_bib39","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1245\/s10434-022-11891-9","article-title":"Use of neoadjuvant imatinib to facilitate minimally invasive resection of gastric gastrointestinal stromal tumors","volume":"29","author":"Li","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.gassur.2024.06.025_bib40","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1007\/s00464-022-09014-2","article-title":"Trends and outcomes of minimally invasive surgery for gastrointestinal stromal tumors (GIST)","volume":"36","author":"Gevorkian","year":"2022","journal-title":"Surg Endosc"},{"issue":"5","key":"10.1016\/j.gassur.2024.06.025_bib41","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jamaoncol.2016.5751","article-title":"Effect of KIT and PDGFRA mutations on survival in patients with gastrointestinal stromal tumors treated with adjuvant imatinib: an exploratory analysis of a randomized clinical trial","volume":"3","author":"Joensuu","year":"2017","journal-title":"JAMA Oncol"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X24005286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X24005286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T22:08:31Z","timestamp":1738447711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X24005286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1091255X24005286"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2024.06.025","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilization of neoadjuvant therapy for localized gastric gastrointestinal stromal tumors and the association with survival","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2024.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}